Internal Medicine, Hematology & Oncology · Quincy, IL
NPI
1477526259
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
3301 Broadway
Quincy, IL, 62301
Phone (217) 277-3500
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.9M
146,674 services
Medicare patients, 2024
835
Average age 75
Drug cost, 2024
$5.3M
2,282 prescriptions
Company payments, 2025
$2,569
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raymond P Smith was code J1439 (injection, ferric carboxymaltose, 1 mg), 30,000 times for 30 patients. In total Raymond P Smith billed 146,674 services in 148 codes, and Medicare paid $2.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 30,000 | 30 | $0.87 | $26K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 14,000 | 27 | $44.75 | $626K |
| J0897 Injection, denosumab, 1 mg | Office | 7,560 | 47 | $20.49 | $155K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 6,800 | 16 | $2.35 | $16K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 5,400 | 24 | $0.09 | $485 |
| J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 4,650 | 21 | $38.52 | $179K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,602 | 58 | $0.09 | $144 |
| 99214 Office E&M - Established | Office | 949 | 346 | $89.70 | $85K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 800 | 18 | $0.23 | $186 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 800 | 38 | $0.26 | $206 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 600 | 33 | $0.74 | $441 |
| J9181 Injection, etoposide, 10 mg | Office | 573 | 11 | $0.83 | $473 |
| Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | Office | 492 | 21 | $110.60 | $54K |
| 99213 Office E&M - Established | Office | 437 | 329 | $57.19 | $25K |
| 96413 Chemotherapy Administration | Office | 284 | 110 | $93.20 | $26K |
By year: 2022 $3.0M for 201,792 services; 2023 $3.0M for 179,021 services; 2024 $2.9M for 146,674 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 47 | 33 | $7.67 | $360 |
| 80053 Clinical Chemistry | 42 | 32 | $10.43 | $438 |
| 36415 Venipuncture Blood Collection | 38 | 27 | $2.96 | $113 |
Medicare prescription drug claims, 2024
In 2024, the drug Raymond P Smith prescribed most often to Medicare patients was Letrozole, with 213 prescriptions and refills. In total Raymond P Smith wrote 2,282 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 213 | 410 | 52 | $2,960 |
| Anastrozole Generic | 116 | 272 | 31 | $2,020 |
| Acyclovir Generic | 109 | 137 | 22 | $1,361 |
| Gabapentin Generic | 105 | 127 | 20 | $1,606 |
| Hydroxyurea Generic | 94 | 173 | 18 | $1,455 |
| Xarelto Rivaroxaban | 77 | 127 | 16 | $69K |
| Exemestane Generic | 75 | 119 | 14 | $5,762 |
| Prednisone Generic | 74 | 86 | 26 | $459 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 59 | 59 | 26 | $1,876 |
| Eliquis Apixaban | 53 | 67 | Under 11 | $40K |
| Ondansetron Hcl Generic | 53 | 53 | 28 | $1,112 |
| Revlimid Lenalidomide | 52 | 52 | Under 11 | $968K |
| Warfarin Sodium Generic | 51 | 63 | Under 11 | $267 |
| Prochlorperazine Maleate Generic | 47 | 47 | 29 | $591 |
| Calquence Acalabrutinib Maleate | 46 | 46 | Under 11 | $623K |
Brand drugs: 460 claims; generic drugs: 1,822 claims; opioid claims: 152.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raymond P Smith $2,569 ($2,569 in general payments such as food, travel and fees) from 36 companies. The largest payer was Novartis Pharmaceuticals Corporation with $320.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 15 | $320 |
| Merck Sharp & Dohme LLC MRK | 17 | $296 |
| Astellas Pharma US Inc 4503.T | 8 | $210 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $177 |
| Daiichi Sankyo Inc. 4568.T | 7 | $155 |
| Pfizer Inc. PFE | 6 | $126 |
| GlaxoSmithKline, LLC. GSK | 5 | $111 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $86.58 |
| Abbvie Inc. ABBV | 4 | $82.21 |
| Gilead Sciences, Inc. GILD | 4 | $75.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.